Jazz Pharmaceuticals
JAZZ
#2195
Rank
NZ$11.98 B
Marketcap
$198.23
Share price
6.75%
Change (1 day)
-11.97%
Change (1 year)

Earnings for Jazz Pharmaceuticals (JAZZ)

Earnings in 2024 (TTM): NZ$0.48 Billion

According to Jazz Pharmaceuticals's latest financial reports the company's current earnings are NZ$3.90 Billion. In 2023 the company made an earning of NZ$0.49 Billion, an increase over its 2022 earnings that were of -NZ$0.63 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Jazz Pharmaceuticals from 2005 to 2024

Annual earnings

Year Earnings Change
2024 (TTM) NZ$0.48 B-1.8%
2023 NZ$0.49 B-179.92%
2022 -NZ$0.63 Billion230.37%
2021 -NZ$0.19 Billion-141.02%
2020 NZ$0.45 B-39.45%
2019 NZ$0.75 B-14.2%
2018 NZ$0.88 B20.03%
2017 NZ$0.73 B-17.15%
2016 NZ$0.88 B22.14%
2015 NZ$0.72 B187.64%
2014 NZ$0.25 B-50.79%
2013 NZ$0.51 B73.63%
2012 NZ$0.29 B41.69%
2011 NZ$0.20 B116.61%
2010 NZ$96.2 M262.77%
2009 NZ$26.51 M-111.33%
2008 -NZ$0.24 Billion1.31%
2007 -NZ$0.24 Billion77.8%
2006 -NZ$0.13 Billion36.59%
2005 -NZ$95.13 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
-NZ$3.99 Billion-904.36%๐Ÿ‡ฎ๐Ÿ‡ช Ireland
NZ$3.49 B 605.10%๐Ÿ‡บ๐Ÿ‡ธ USA
NZ$21.19 B 4,181.55%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
NZ$1.37 B 178.11%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel